NCT06402981View on ClinicalTrials.gov

A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Immune Checkpoint InhibitorsLiver Injury
Interventions
OTHER

High risk prediction model for liver injury

Risk Prediction Model for Liver Injury After Use of PD-1/PD-L1 Inhibitors

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Zhejiang University

OTHER